FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation
FRA:FME • DE0005785802
Current stock price
37.74 EUR
-0.53 (-1.38%)
Last:
This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FME.DE Profitability Analysis
1.1 Basic Checks
- In the past year FME was profitable.
- FME had a positive operating cash flow in the past year.
- FME had positive earnings in each of the past 5 years.
- In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.16%, FME is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
- FME has a Return On Equity (7.35%) which is comparable to the rest of the industry.
- FME has a Return On Invested Capital of 5.30%. This is comparable to the rest of the industry: FME outperforms 54.55% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.44%.
- The 3 year average ROIC (4.02%) for FME is below the current ROIC(5.30%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROIC | 5.3% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
1.3 Margins
- The Profit Margin of FME (4.98%) is better than 78.79% of its industry peers.
- FME's Profit Margin has declined in the last couple of years.
- With a decent Operating Margin value of 9.00%, FME is doing good in the industry, outperforming 66.67% of the companies in the same industry.
- In the last couple of years the Operating Margin of FME has declined.
- FME has a Gross Margin of 25.62%. This is in the better half of the industry: FME outperforms 60.61% of its industry peers.
- FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% |
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
2. FME.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
- FME has less shares outstanding than it did 1 year ago.
- Compared to 5 years ago, FME has less shares outstanding
- Compared to 1 year ago, FME has a worse debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 2.15 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 2.15, FME is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
- The Debt to FCF ratio of FME is 6.19, which is on the high side as it means it would take FME, 6.19 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 6.19, FME is doing good in the industry, outperforming 75.76% of the companies in the same industry.
- A Debt/Equity ratio of 0.65 indicates that FME is somewhat dependend on debt financing.
- The Debt to Equity ratio of FME (0.65) is better than 78.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.91
WACC5.8%
2.3 Liquidity
- A Current Ratio of 1.26 indicates that FME should not have too much problems paying its short term obligations.
- FME has a better Current ratio (1.26) than 66.67% of its industry peers.
- FME has a Quick Ratio of 1.26. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
- FME has a Quick ratio (0.92) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 |
3. FME.DE Growth Analysis
3.1 Past
- FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
- Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.51% on average per year.
- The Revenue has been growing slightly by 1.51% in the past year.
- Measured over the past years, FME shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
3.2 Future
- FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
- FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.69% yearly.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. FME.DE Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.80, the valuation of FME can be described as very reasonable.
- Based on the Price/Earnings ratio, FME is valued cheaply inside the industry as 96.97% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 25.23. FME is valued rather cheaply when compared to this.
- A Price/Forward Earnings ratio of 9.41 indicates a reasonable valuation of FME.
- 90.91% of the companies in the same industry are more expensive than FME, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of FME to the average of the S&P500 Index (23.28), we can say FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.8 | ||
| Fwd PE | 9.41 |
4.2 Price Multiples
- FME's Enterprise Value to EBITDA is on the same level as the industry average.
- FME's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.09 | ||
| EV/EBITDA | 8.99 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%
5. FME.DE Dividend Analysis
5.1 Amount
- FME has a Yearly Dividend Yield of 3.76%.
- Compared to an average industry Dividend Yield of 1.79, FME pays a better dividend. On top of this FME pays more dividend than 96.97% of the companies listed in the same industry.
- FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
5.2 History
- The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
- 43.19% of the earnings are spent on dividend by FME. This is a bit on the high side, but may be sustainable.
- The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FME.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:FME (3/20/2026, 7:00:00 PM)
37.74
-0.53 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24 2026-02-24/dmh
Earnings (Next)05-05 2026-05-05
Inst Owners44.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.08B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.79 (21.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.76% |
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.01%
PT rev (3m)-4.33%
EPS NQ rev (1m)30.25%
EPS NQ rev (3m)30.25%
EPS NY rev (1m)-3.3%
EPS NY rev (3m)-3.16%
Revenue NQ rev (1m)-5.71%
Revenue NQ rev (3m)-5.71%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-2.06%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.8 | ||
| Fwd PE | 9.41 | ||
| P/S | 1.07 | ||
| P/FCF | 12.09 | ||
| P/OCF | 7.86 | ||
| P/B | 1.58 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.99 |
EPS(TTM)4.29
EY11.37%
EPS(NY)4.01
Fwd EY10.62%
FCF(TTM)3.12
FCFY8.27%
OCF(TTM)4.8
OCFY12.72%
SpS35.14
BVpS23.83
TBVpS-2.71
PEG (NY)N/A
PEG (5Y)N/A
Graham Number47.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROCE | 7.13% | ||
| ROIC | 5.3% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 16.63% | ||
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% | ||
| FCFM | 8.88% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Debt/EBITDA | 2.64 | ||
| Cap/Depr | 62.47% | ||
| Cap/Sales | 4.78% | ||
| Interest Coverage | 4.9 | ||
| Cash Conversion | 82.09% | ||
| Profit Quality | 178.22% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 2.15 |
F-Score8
WACC5.8%
ROIC/WACC0.91
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year71.81%
EBIT Next 3Y24.11%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%
FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status for FME stock?
ChartMill assigns a valuation rating of 5 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE AG?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.
What is the valuation of FRESENIUS MEDICAL CARE AG based on its PE and PB ratios?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 8.8 and the Price/Book (PB) ratio is 1.58.
How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.